22 results
8-K
EX-10.1
DMAC
DiaMedica Therapeutics Inc.
29 Jun 22
Entry into a Material Definitive Agreement
4:30pm
as an Operating Expense.
7.2 Tenant’s Responsibilities. Tenant shall not permit waste to the Premises and shall promptly notify Landlord of the need … . REPAIRS-ALTERATIONS.
Tenant shall not damage the Premises and shall not permit waste to the Premises. Tenant shall not make any improvements, additions
424B3
DMAC
DiaMedica Therapeutics Inc.
15 Oct 21
Prospectus supplement
6:32am
a significant amount of byproduct waste. Our novel recombinant manufacturing process utilizes widely available raw materials and can be readily scaled
424B5
5gavadu f52dz
10 Aug 20
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
6rqfng9
5 Aug 20
Updated Financial Information
4:33pm
424B5
wwnjq hogwe1ooh2k6bj
5 Aug 20
Prospectus supplement for primary offering
4:30pm
424B5
mu0ynrgduv6poolm9a
11 Feb 20
Prospectus supplement for primary offering
5:31pm
424B5
qxt nspce3v
11 Feb 20
Prospectus supplement for primary offering
7:02am
10-K
emi32nz qu39o0
19 Mar 19
Annual report
4:58pm
424B4
szm6f 0p6f8opj43bq
10 Dec 18
Prospectus supplement with pricing info
4:50pm
S-1/A
bvfh1
19 Nov 18
IPO registration (amended)
5:01pm
S-1
95es3b2m
9 Nov 18
IPO registration
4:21pm
S-1
EX-10.8
zr0u31zkpswl jid
9 Nov 18
IPO registration
4:21pm
DRS
EX-10.8
p3guh8obkkc
1 Nov 18
Draft registration statement
12:00am